


Another Name飞尼妥,LuciEver,Afinitor
IndicationsIndicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer; neuroendocrine tumors of pancreatic, gastrointestinal, and pulmonary origin; advanced renal cell carcino
Reg No.02 L 1303/25
Inspection No.425-25
WhatsApp: